Sandesh Mahatme is a director of Aeglea BioTherapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aeglea BioTherapeutics, Inc.
9 Jun 22
4
Aeglea BioTherapeutics, Inc.
9 Jun 21
4
Sarepta Therapeutics, Inc.
9 Jul 20
4
Flexion Therapeutics Inc
12 Jun 20
4
Aeglea BioTherapeutics, Inc.
10 Jun 20
4
Sarepta Therapeutics, Inc.
28 Feb 20
4
Sarepta Therapeutics, Inc.
17 Dec 19
4
Sarepta Therapeutics, Inc.
22 Aug 19
4
Sarepta Therapeutics, Inc.
15 Aug 19
4
Flexion Therapeutics Inc
21 Jun 19
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Jun 22 | AGLE Aeglea BioTherapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 0.73 | 43,000 | 31.39 k | 43,000 |